Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVL
826
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $55.8M | 0.01% |
2,417,690
+3,622
| +0.2% | +$45.9K |
|
827
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.41B
| $55.8M | 0.01% |
771,800
-227,300
| -23% | -$14.1M |
|
828
CALL
Clorox
CLX
$12.8B
| $55.6M | 0.01% |
275,600
-314,800
| -53% | -$65.1M |
|
|
NVRO
829
DELISTED
NEVRO CORP.
NVRO
| $55.6M | 0.01% |
321,478
+132,181
| +70% | +$21.4M |
|
830
Charles River Laboratories
CRL
$13.6B
| $55.4M | 0.01% |
221,790
+171,542
| +341% | +$40.9M |
|
831
Sociedad Química y Minera de Chile
SQM
$20.4B
| $55.3M | 0.01% |
1,126,120
+814,804
| +262% | +$34.3M |
|
832
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $55.3M | 0.01% |
1,041,843
+569,062
| +120% | +$28.2M |
|
833
The Mosaic Company
MOS
$6.92B
| $55.3M | 0.01% |
2,401,247
+164,270
| +7% | +$3.31M |
|
834
PUT
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
| $55.2M | 0.01% |
2,277,600
+535,200
| +31% | +$13.3M |
|
835
iShares China Large-Cap ETF
FXI
$4.16B
| $55M | 0.01% |
1,185,278
-167,701
| -12% | -$7.65M |
|
836
Elastic
ESTC
$8.02B
| $55M | 0.01% |
376,248
+144,820
| +63% | +$17.8M |
|
837
TechnipFMC
FTI
$29.5B
| $54.9M | 0.01% |
7,852,562
-13,103,567
| -63% | -$77M |
|
|
XLNX
838
CALL
DELISTED
Xilinx Inc
XLNX
| $54.6M | 0.01% |
385,400
-254,400
| -40% | -$33.1M |
|
839
PUT
Blackstone
BX
$110B
| $54.6M | 0.01% |
843,000
+136,900
| +19% | +$7.97M |
|
840
CALL
iShares MSCI Japan ETF
EWJ
$23.2B
| $54.6M | 0.01% |
808,300
+554,900
| +219% | +$34.9M |
|
841
CF Industries
CF
$18.2B
| $54.6M | 0.01% |
1,410,149
+701,493
| +99% | +$23.2M |
|
842
McKesson
MCK
$102B
| $54.3M | 0.01% |
312,111
+292,434
| +1,486% | +$48.7M |
|
843
PUT
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $54.2M | 0.01% |
189,100
+156,600
| +482% | +$39.9M |
|
|
ACIA
844
DELISTED
Acacia Communications Inc
ACIA
| $54.2M | 0.01% |
743,014
-836,584
| -53% | -$57.8M |
|
845
MarketAxess Holdings
MKTX
$5.72B
| $54.2M | 0.01% |
94,973
-61,206
| -39% | -$33.3M |
|
846
CALL
RingCentral
RNG
$5.25B
| $54.1M | 0.01% |
142,800
-58,500
| -29% | -$18.2M |
|
847
COPT Defense Properties
CDP
$4.19B
| $54.1M | 0.01% |
2,073,776
-198,884
| -9% | -$5.02M |
|
848
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| $53.9M | 0.01% |
528,587
+339,108
| +179% | +$34.6M |
|
849
Zscaler
ZS
$28.7B
| $53.9M | 0.01% |
270,040
-474,647
| -64% | -$75.5M |
|
|
UMPQ
850
DELISTED
Umpqua Holdings Corp
UMPQ
| $53.7M | 0.01% |
3,548,367
-1,317,330
| -27% | -$18.1M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.